Francois Nader - 15 Dec 2021 Form 4 Insider Report for Talaris Therapeutics, Inc. (TRML)

Role: Director
Signature: /s/ Mary Kay Fenton, attorney-in-fact
Issuer symbol: TRML
Transactions as of: 15 Dec 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Dec 2021, 15:05:23 UTC
Previous filing: 22 Nov 2021
Next filing: 02 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TALS	Common Stock	Gift	$0	-59,520	-15%	$0.000000	336,167	15 Dec 2021	By Francois Nader 2020 Trust	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held in a trust for the benefit of the reporting person's spouse and child. The reporting person's spouse and child are trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

These shares are held in a trust for the benefit of the reporting person's spouse and child. The reporting person's spouse and child are trustees of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.